Shield Therapeutics Share Discussion Threads

[antonagis] 07/12/2024 01:04

Disciple ZEUS looking after his master PURCHASEATTHETOP

[zeus19] 06/12/2024 19:49

Youre making yourself look like a clown stalking PATT

[purchaseatthetop] 06/12/2024 18:38

Why? In Oct 24 when they proposed the equity injection it was a 5.3% premium. Why should they pay a 35% premium now that the share price has fallen. They are paying a 5.3% premium still. I have bought three times at 2.85p in the last month or so. I will buy again at levels lower than the 3p.

Not sure why that is ridiculous.

[best1467] 06/12/2024 18:33

Your comment the 3p placing is. Comparable to the 4p.Do you honestly believe you can convince people to believe that ridiculous comment.To be totally honest it’s slightly distasteful remark

[purchaseatthetop] 06/12/2024 17:29

Thaiger.

“maximum of 33,333,333 RetailBook Offer Shares will be issued and accordingly, the maximum gross proceeds of the RetailBook Offer are £1,000,000
· The RetailBook Offer is expected to close at 4.30 p.m. on 20 December 2024;”

The company will want that £1m. I now expect some update before 20/12 that sends the share price above 3p. Making the offer very attractive.

But anyway, now that cashflow snd covenants are sorted and AOP are backstopping everybody else (as we forecast because the loan owns all the IP if defaulted) this sub 3p price is amazing.

[thaiger] 06/12/2024 17:10

Who's going to take up the Retail Offer of 3p when you can buy at lower price even allowing for dealing charges?

[dodge_city] 06/12/2024 16:41

Is this being prepped for a cheap takeover.

[qipincha] 06/12/2024 16:30

BOD of AOP having 26M stx share, is a good thing to know

[dplewis1] 06/12/2024 14:45

An ever declining share price with ever greater dilution.. just like Enet

[purchaseatthetop] 06/12/2024 14:40

The Company's largest shareholder, AOP, executed a non-binding term sheet at the same time to subscribe for new Ordinary Shares at a subscription price of 4.0 pence per Ordinary Share, which would raise aggregate gross proceeds of at least $10 million. The 4.0 pence price represented a 5.3% premium to the closing middle market price of an Ordinary Share on 28 October 2024.

The 3p is exactly the same 5.3% premium as the original plan.

[weatherman] 06/12/2024 14:28

Offer at 3p, what happened to 4p ?

[purchaseatthetop] 06/12/2024 14:27

Very reassuring to have the $10m sorted.

Q4 24 revenue should be about…

US product sales of $9.7m with 45% gross margin so $4.4m contribution
Other revenues of $1.8m with 90% gross margin so $1.6m contribution
Total Q4 contribution of $6m
Total overhead of about $9m
So ballpark cash burn of $3m

Every quarter the US product sales will rise and eat away at cash burn. Nearly there now. Hopefully. When the 3p shares are completed on 24/12 we will see the benefits finally.

[dplewis1] 06/12/2024 13:44

There was no need for an equity raise according to pilfering patt. Now there's been one it's apparently a good thing. Usual buffoonery from the resident charity conman

[purchaseatthetop] 06/12/2024 13:04

That equity raise also sorts any small covenant shortfall Q1 25. Which is good. Q2 25 should all be fine as the revenue targets then plateau.

[dplewis1] 06/12/2024 13:02

Bargepole. Never invest in a company with such a large holding concentrated in one place. Small shareholders are the stuffees as usual

[purchaseatthetop] 06/12/2024 12:38

Don’t think so Socionomics. Why would anybody pay more than 3p till after the shares issued? Then we will be off to the races!

[socionomics] 06/12/2024 12:30

Mates onboard, and we're off to the races.

[base7] 06/12/2024 12:13

Will Anderson & Santos be subscribing ?

[purchaseatthetop] 06/12/2024 12:13

Just for a laugh. Target price 30p just out.

[skcots48] 06/12/2024 11:59

It happens or they run out of moneySo shareholders have little choice unless they want their investment to be dust

[qipincha] 06/12/2024 11:47

AOP (excluding its concert parties) currently holds 311,597,265 Ordinary Shares, representing 39.84 per cent. of the Company's issued share capital. The AOP Directors and persons acting in concert with AOP currently hold, in aggregate, 327,873,978 Ordinary Shares, representing 41.93 per cent. of the Company's issued share capital.

Interesting, so the BOD of AOP hold about 26M of stx

[fhmktg] 06/12/2024 11:35

That’s one hell of an update!
Where does that leave existing holders?

[purchaseatthetop] 06/12/2024 11:21

I don’t think we will get any improvement without an update.
Which I expect around 20/12/24 along with the 21 day notice of a GM to approve the AOP $10m equity.
Maybe November figures snd average Rx price.

Where it will really shift is Q2/3 2025. Assuming adding around 7k prescriptions per quarter we will be at 65k in Q2 25. Then paediatric approval will just about cause an instant 20% rise. That would make Q3 25 about 85k at say $220.

Hardman are expecting $70m revenue in 2025 snd I think this paediatric jump is key to the rise from $31m in 2024.

[r9505571] 06/12/2024 11:11

Where's the Santa rally?

[dplewis1] 06/12/2024 09:56

Incompetent management hoping their overpriced one trick pony will get them to breakeven. Highly unlikely given past performance .. even paid brokers like Stifel only have a 3.5p 2025 year ended target. Not very attractive given the risks involved